Cheapest GLP-1 Plans Without Insurance (2026)

Maximus offers compounded semaglutide at $99.99/month for the first 15 weeks, then $132.99/month — a Year 1 total of $1,464. tonik and Gala both start at $149/month ($1,788/year).

MadeMed offers oral semaglutide at $129/month plus a $149/year membership — a Year 1 total of $1,697. Shed offers Foundayo at $149/month with no membership ($1,788/year).

Brand-name GLP-1s (Ozempic, Wegovy, Zepbound) are FDA-approved drugs costing $1,000–$1,500/month without insurance. Compounded GLP-1s contain the same active ingredient from licensed 503B pharmacies at 60–80% lower cost. They are not FDA-approved products but are legal while brand-name versions remain on the FDA shortage list.

Semaglutide targets the GLP-1 receptor. Tirzepatide targets both GLP-1 and GIP receptors, producing greater average weight loss (~22% vs ~15%) in clinical trials. Tirzepatide costs more but may deliver stronger results. Both require a prescription and dose escalation over several months.

Yes. All clinics listed require a prescription from a licensed provider. All offer telehealth consultations — you complete a health questionnaire and speak with a clinician digitally. No in-person visit required.

A microdose is a very low starting dose used to minimize nausea. Maximus and Gala offer microdose options from $79.99–$99.99/month. They're cheaper but progress more slowly to therapeutic doses — best for patients sensitive to side effects.

Most patients notice appetite suppression within 2–4 weeks. Meaningful weight loss (5–10%) typically occurs within 3–6 months at therapeutic dose. Clinical trials show 15–22% body weight reduction over 68 weeks.

The clinics on our list are licensed telehealth providers using 503B-registered compounding pharmacies. Compounded GLP-1s are not FDA-approved but are legally produced while brand-name versions are on the FDA shortage list. Verify pharmacy licensure at nabp.pharmacy and always consult your physician first.